Mino-Lok®
Catheter-related bloodstream infections (CRBSIs)
Phase 3Active
Key Facts
Indication
Catheter-related bloodstream infections (CRBSIs)
Phase
Phase 3
Status
Active
Company
About Citius Pharmaceuticals
Citius Pharmaceuticals is a publicly traded, late-stage biopharma company focused on addressing unmet needs in critical care and oncology. The company has built a diversified pipeline with three main candidates, including the recently FDA-approved LYMPHIR™. With significant founder investment and a focus on products with large market potential, Citius aims to bring novel therapies to market faster.
View full company profile